BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7390722)

  • 1. Inferred natural history of uveal melanoma.
    McLean IW; Foster WD; Zimmerman LE; Martin DG
    Invest Ophthalmol Vis Sci; 1980 Jul; 19(7):760-70. PubMed ID: 7390722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
    Hawkins BS;
    Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of malignant melanoma of the choroid: small vs large tumors.
    Davidorf FH; Lang JR
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(2):OP310-20. PubMed ID: 1145955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Follow-up after enucleation in choroid melanoma].
    Gliem H; Gelb W; Wolf T; Trinkmann R
    Fortschr Ophthalmol; 1989; 86(3):242-4. PubMed ID: 2759535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term surgical outcome of posterior choroidal melanoma treated by endoresection.
    Karkhaneh R; Chams H; Amoli FA; Riazi-Esfahani M; Ahmadabadi MN; Mansouri MR; Nouri K; Karkhaneh A
    Retina; 2007 Sep; 27(7):908-14. PubMed ID: 17891016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural history of malignant melanoma of the choroid].
    Saraux H; Pelosse B
    J Fr Ophtalmol; 1988; 11(2):169-75. PubMed ID: 3171096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In malignant choroidal melanoma will a delay in radical treatment influence prognosis?
    Packard RB
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():49-53. PubMed ID: 6581635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival after treatment for malignant choroidal melanoma: comparison between conservative therapy (Ru106/Rh106 applicator) and enucleation with and without postoperative irradiation to the orbit; 1960 to 1979].
    Kiehl H; Kirsch I; Lommatzsch P
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):2-14. PubMed ID: 6708380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of histopathologic findings in malignant melanoma of the choroid and ciliary body with special reference to regressive changes].
    Faber W; Kock E
    Klin Monbl Augenheilkd; 1982 Dec; 181(6):458-64. PubMed ID: 7169770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors of choroidal melanoma: an anatomo-clinical retrospective and statistical study of 76 enucleated cases].
    Panigel K; Hedelin G; Speeg-Schatz C; Sahel J; Brini A
    J Fr Ophtalmol; 1992; 15(6-7):410-4. PubMed ID: 1294598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye-wall resection.
    Char DH; Miller T; Crawford JB
    Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late results in treating uveal melanomas. A comparative evaluation of enucleation and organ-preserving treatment methods].
    Libman ES; Brovkina AF; Bezrukov AV
    Oftalmol Zh; 1989; (6):336-8. PubMed ID: 2622596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.